Tiziana Rossetti

Tiziana Rossetti, PhD, is an accomplished professional in the fields of venture capital and biomedical research, currently serving as Principal at Sofinnova Partners since May 2019. Prior to this, Tiziana held the position of Senior Analyst at Innogest Capital, focusing on investments in early-stage healthcare startups, and worked as a Business Analyst at Merck Ventures. Tiziana has extensive experience in start-up management as the CEO and Founder of Cogmaze Diagnostics and has contributed to research at leading institutions, including the Hertie Institute and the Medical Research Council. Tiziana's academic background includes a PhD in Clinical Neuroscience from Royal Holloway, University of London, and various degrees in Neurobiology and Molecular and Cellular Biology from La Sapienza University. Additionally, Tiziana participated in business education programs at Santa Clara University and University of Tübingen.